| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.095 | 0.002 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |